Ulrich Guller
Expertise in
2
conditions

Ulrich Guller

Bern, BE, CH 
Expertise in
2
conditions
Bern, BE, CH 

Overview

Ulrich Guller practices practicing medicine in Bern, Switzerland.

Mr. Guller is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Sclerosing Mesenteritis, Hernia, Bone Marrow Aspiration, and Gallbladder Removal.

He is actively involved in clinical research, co-authoring 60 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Bern, BE, Switzerland
Other Locations
Spital STS AG
Thun, BE, Switzerland
Spital STS Thun, Schlieren / Spital, ZH, Switzerland
Kantonsspital St. Gallen, Sankt Gallen, SG 9007, Switzerland
Kantonsspital St Gallen, Switzerland
Kantonsspital Frauenfeld, Spital Thurgau AG
Frauenfeld, TG 8500, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Enrollment Status: Terminated
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 3
Prospective Cohort Study With Collection of Clinical Data, Serum and Plasma of Patients With Prostate Disease
Prospective Cohort Study With Collection of Clinical Data, Serum and Plasma of Patients With Prostate Disease
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2022
Intervention Type: Other
View 1 Less Clinical Trial

60 Total Publications

Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial.
Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 05, 2024

Frequently Asked Questions about Ulrich Guller

Is Ulrich Guller a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ulrich Guller is classified as an Advanced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ulrich Guller participate in research or clinical trials?

Yes. Ulrich Guller has published 60 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Ulrich Guller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guller's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile